Skip to content

SCHEDULE 13GAccepted Feb 13, 4:10 PM ET

Evommune, Inc. SCHEDULE 13G

Pivotal bioVenture Partners Fund I, L.P.

Accepted (ET)

4:10 PM

Feb 13, 2026

Filed

Feb 13, 2026

Documents

2

Size

108.5 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.